Literature DB >> 4323457

Studies on the antiviral effect of rifampicin in volunteers.

A Moshkowitz, N Goldblum, E Heller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4323457     DOI： 10.1038/229422a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  4 in total

1.  Immunological responsiveness of tuberculosis patients receiving rifampin.

Authors:  F L Ruben; A Winkelstein; I G Fotiadis
Journal:  Antimicrob Agents Chemother       Date:  1974-04       Impact factor: 5.191

Review 2.  The current understanding and potential therapeutic options to combat COVID-19.

Authors:  Venkatesh Pooladanda; Sowjanya Thatikonda; Chandraiah Godugu
Journal:  Life Sci       Date:  2020-05-08       Impact factor: 5.037

Review 3.  Rifampicin for COVID-19.

Authors:  George D Panayiotakopoulos; Dimitrios T Papadimitriou
Journal:  World J Virol       Date:  2022-03-25

4.  Small Animal Model of Post-chemotherapy Tuberculosis Relapse in the Setting of HIV Co-infection.

Authors:  Matthew B Huante; Tais B Saito; Rebecca J Nusbaum; Kubra F Naqvi; Sadhana Chauhan; Robert L Hunter; Jeffrey K Actor; Jai S Rudra; Mark A Endsley; Joshua G Lisinicchia; Benjamin B Gelman; Janice J Endsley
Journal:  Front Cell Infect Microbiol       Date:  2020-04-16       Impact factor: 5.293
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.